Update shared on 17 Nov 2025
Fair value Decreased 6.25%Analysts have lowered their price target for Grifols from $16.48 to $15.45, citing modestly reduced revenue growth expectations and a lower future price-to-earnings multiple. This comes despite slightly improved profit margins and a more favorable discount rate.
What's in the News
- The Grifols board will convene on September 25, 2025, to establish a Strategy Committee responsible for advising and making proposals on key strategic initiatives (Key Developments).
- The Board of Directors is also set to consider additional matters at the upcoming meeting (Key Developments).
- A similar board meeting is scheduled for September 26, 2025, confirming the creation of the Strategy Committee with an advisory role (Key Developments).
Valuation Changes
- Consensus Analyst Price Target has decreased from €16.48 to €15.45.
- Discount Rate has fallen significantly from 10.16% to 8.05%.
- Revenue Growth expectations have edged down slightly from 6.00% to 5.96%.
- Net Profit Margin has risen modestly from 10.07% to 10.50%.
- Future P/E has decreased notably from 17.22x to 14.11x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.